A 59-year-old man with large B cell lymphoma was admitted to the hospital due to neutropenic fever. He had been diagnosed 15 months prior and received six cycles of rituximab-etoposide-prednisone-vincristine-cyclophosphamide-doxorubicin chemotherapy with 3 weeks between each cycle. His lymphoma recurred 4 months prior to admission necessitating initiation of an alternative chemotherapeutic regimen. Physical examination revealed that the first toenail on each foot had multiple horizontal, depressed white lines, known as Beau’s lines (Fig. 1) but the other toenails and all fingernails were normal. Beau’s lines are horizontal indentations of the nail caused by cessation of cell division of the nail plate.1 Beau’s lines can be caused by localized stressors such as mechanical trauma as well as systemic stressors such as myocardial infarction, chemotherapy, and influenza.2 In this instance, each Beau’s line correlated with one cycle of cytotoxic chemotherapy.3 The patient said that he had similar lines on his fingernails and other (shorter) toenails, but these lines had already grown out. The average fingernail grows at 3.5 mm/month and toenail grows at a rate of 1.6 mm/month.4 Nail changes are seen more commonly due to anthracycline agents.5 In this instance, the Beau’s lines correlated with each cycle of doxorubicin he received during his first chemotherapy regimen.
Figure 1.
First toe with Beau’s lines.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they do not have a conflict of interest.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Cindy Piao, Email: cpiao@ucdavis.edu.
Paul B. Aronowitz, Email: Paronowitz@ucdavis.edu.
References
- 1.Piraccini BM, Iorizzo M, Starace M, Tosti A. Drug-induced Nail Diseases. Dermatol Clin. 2006;24(3):387–391. doi: 10.1016/J.DET.2006.03.004. [DOI] [PubMed] [Google Scholar]
- 2.Zaiac MN, Walker A. Nail abnormalities associated with systemic pathologies. Clin Dermatol. 2013;31(5):627–649. doi: 10.1016/J.CLINDERMATOL.2013.06.018. [DOI] [PubMed] [Google Scholar]
- 3.Hinds G, Thomas VD. Malignancy and Cancer Treatment-Related Hair and Nail Changes. Dermatol Clin. 2008;26(1):59–68. doi: 10.1016/J.DET.2007.08.003. [DOI] [PubMed] [Google Scholar]
- 4.Yaemsiri S, Hou N, Slining M, He K. Growth rate of human fingernails and toenails in healthy American young adults. J Eur Acad Dermatology Venereol. 2010;24(4):420–423. doi: 10.1111/j.1468-3083.2009.03426.x. [DOI] [PubMed] [Google Scholar]
- 5.Robert C, Sibaud V, Mateus C, et al. Nail toxicities induced by systemic anticancer treatments. Lancet Oncol. 2015;16(4):e181–9. doi: 10.1016/S1470-2045(14)71133-7. [DOI] [PubMed] [Google Scholar]